We are live on ! Find out more
AC

Almitas Capital Portfolio holdings

AUM $443M
1-Year Est. Return 42.36%
This Fund
S&P 500
This Quarter Est. Return
+15.52%
1 Year Est. Return
+42.36%
3 Year Est. Return
+85.86%
5 Year Est. Return
10 Year Est. Return
AUM
$456M
AUM Growth
+$173M
Cap. Flow
+$144M
Cap. Flow %
31.61%
Top 10 Hldgs %
67%
Holding
112
New
44
Increased
25
Reduced
13
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXE
26
DELISTED
MFS High Income Municipal Trust
CXE
$3.39M 0.74%
921,837
+200,984
+28% +$770K
NPCT icon
27
Nuveen Core Plus Impact Fund
NPCT
$279M
$2.83M 0.62%
269,668
-85,638
-24% -$963K
MIO
28
DELISTED
Pioneer Municipal High Income Opportunities Fund
MIO
$2.74M 0.6%
231,057
+128,460
+125% +$1.56M
ZTR
29
Virtus Total Return Fund
ZTR
$340M
$2.56M 0.56%
437,074
+129,284
+42% +$777K
AVIR icon
30
Atea Pharmaceuticals
AVIR
$379M
$2.52M 0.55%
752,003
-632,526
-46% -$2.1M
GLO
31
Clough Global Opportunities Fund
GLO
$249M
$2.33M 0.51%
455,226
+292,285
+179% +$1.55M
IIF
32
Morgan Stanley India Investment Fund
IIF
$210M
$2.18M 0.48%
86,320
DMA
33
Destra Multi-Alternative Fund
DMA
$68.7M
$2.14M 0.47%
253,418
-53,897
-18% -$474K
ITOS
34
DELISTED
iTeos Therapeutics
ITOS
$2.11M 0.46%
+275,120
New +$2.36M
MAV
35
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$2.07M 0.45%
245,006
+160,289
+189% +$1.39M
ALXO icon
36
ALX Oncology
ALXO
$273M
$2.04M 0.45%
+1,222,945
New +$1.88M
AFB
37
AllianceBernstein National Municipal Income Fund
AFB
$312M
$2.04M 0.45%
187,470
+37,574
+25% +$426K
DX
38
Dynex Capital
DX
$2.99B
$2.02M 0.44%
+159,392
New +$1.99M
BRSP
39
BrightSpire Capital
BRSP
$681M
$2.01M 0.44%
+356,322
New +$2.1M
CEE
40
Central and Eastern Europe Fund
CEE
$135M
$1.97M 0.43%
180,190
+1,983
+1% +$22.5K
MEGI
41
MainStay CBRE Global Infrastructure Megatrends Term Fund
MEGI
$786M
$1.96M 0.43%
+160,901
New +$2.19M
MFIC icon
42
MidCap Financial Investment
MFIC
$784M
$1.83M 0.4%
135,444
+63,491
+88% +$862K
MHI
43
DELISTED
Pioneer Municipal High Income Fund
MHI
$1.81M 0.4%
195,878
+82,347
+73% +$779K
ANTX icon
44
AN2 Therapeutics
ANTX
$177M
$1.81M 0.4%
+1,313,111
New +$1.59M
LADR
45
Ladder Capital
LADR
$1.25B
$1.63M 0.36%
+145,892
New +$1.68M
BTC
46
Grayscale Bitcoin Mini Trust ETF
BTC
$3.4B
$1.49M 0.33%
+35,700
New +$1.31M
BTX
47
BlackRock Technology and Private Equity Term Trust
BTX
$957M
$1.44M 0.31%
193,153
-81,289
-30% -$625K
WIA
48
Western Asset Inflation-Linked Income Fund
WIA
$185M
$1.27M 0.28%
159,057
RLYB icon
49
Rallybio
RLYB
$86.6M
$1.25M 0.27%
162,265
+52,836
+48% +$443K
CMU
50
DELISTED
MFS High Yield Municipal Trust
CMU
$1.21M 0.27%
344,105
+202,845
+144% +$728K

Similar funds

Almitas Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Almitas Capital held 112 positions worth $456M, up 61% from $283M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Almitas Capital deployed $144M of net new capital in Q4 2024, opening 44 new positions and adding to 25 existing holdings. Its largest new stake was Fidelity Ethereum Fund: 941,057 shares worth $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 7.8% of assets, down from 8.9% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Nuveen Pennsylvania Quality Municipal Income Fund, an estimated $4.09M trimmed.

  • Almitas Capital's largest Q4 2024 buy was Fidelity Ethereum Fund: 941,057 shares worth $31.4M.
  • Almitas Capital added most to Fidelity Wise Origin Bitcoin Fund in Q4 2024, an estimated $44.7M increase.
  • Almitas Capital's biggest Q4 2024 reduction was Nuveen Pennsylvania Quality Municipal Income Fund, cutting an estimated $4.09M.
  • Almitas Capital fully exited Miller/Howard High Income Equity Fund in Q4 2024, selling an estimated $13.6M.
  • Almitas Capital's ten largest holdings make up 67% of its $456M portfolio in Q4 2024.
  • Almitas Capital opened 44 new positions and closed 20 in Q4 2024.
  • Almitas Capital's portfolio value rose 61% quarter-over-quarter to $456M.

Based on Almitas Capital's 13F filing for Q4 2024, filed 14 Feb 2025.